Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 5, 2003, Pages 1265-1272

  Todo, Yukiharu ^a   Sakuragi, Noriaki ^a   Nishida, Ryutaro ^a   Yamada, Takashi ^a   Ebina, Yasuhiko ^a   Yamamoto, Ritsu ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CA 125; Endometrial carcinoma lymph node metastasis; Magnetic resonance imaging

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRACTICE GUIDELINE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 0038733996     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.318     Document Type: Article

References (25)

1. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in stage endometrial carcinoma. Am J Obstet Gynecol 1985;151:1009-15.
2. Boronow RC, Morrow CP, Creasman WT, DiSaia PJ, Silverberg SG, Miller A. Surgical staging in endometrial cancer:Clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-32.
3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer 1987;60:2035-41.
4. Takeshima N, Shimizu Y, Umezawa S, Hirai Y, Chen JT, Fujimoto I, et al. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma. Gynecol Oncol 1994;54:321-6.
5. Sood AK, Buller RE, Burger RA, Dawson JD, Sorosky JI, Berman M. Value of preoperative CA125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol 1997;90:441-7.
6. Zurawski VR Jr, Sjovall K, Schoenfeld DA, Broderick SF, Hall P, Bast RC, et al. Prospective evaluation of serum CA125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer. Gynecol Oncol 1990;36:299-305.
7. Alagoz T, Buller RE, Berman M, Anderson B, Manetta A, DiSaia P. What is a normal CA125 level? Gynecol Oncol 1994;53:93-7.
8. Kurihara T, Mizunuma H, Obara M, Andoh K, Ibuki Y, Nishimura T. Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma. Gynecol Oncol 1998:69:192-6.
9. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG. Endometrial carcinoma staging by MR imaging. Radiology 1987;162:297-305.
10. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991;179:829-32.
11. Scoutt LM, McCarthy SM, Flynn SD, Lange RC, Long F, Smith RC, et al. Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Radiology 1995;194:567-72.
12. Demas BE, Hricak H, Jaffe RB. Uterine MR imaging: effects of hormonal stimulation. Radiology 1986;156:123-6.
13. Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P, et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992;185:207-12.
14. Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H, et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;161:595-9.
15. Lee EJ, Byun JY, Kim BS, Koong SE, Shinn KS. Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. Radiographics 1999;19:937-45.
16. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-8.
17. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 1999;9:383-6.
18. Webb GA, Lagios MD. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 1987;156:1486-91.
19. Wilson TO, Podratz KC, Gaffey TA, Malkasian GD, O'Brien PC, Naessens JM. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990;162:418-26.
20. Abeler VM, Kjorstad KE. Serous papillary carcinoma of the endometrium: a histopathologic study of 22 cases. Gynecol Oncol 1990;39:266-71.
21. Sakuragi N, Hareyama H, Todo Y, Yamada H, Yamamoto R, Fujino T, et al. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand 2000;79:311-6.
22. Lampe B, Kurzl R, Hantschmann P. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma. Cancer 1994;74:2502-8.
23. Goff BA, Kato D, Schmidt RA, El M, Ferry JA, Muntz HG, et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994;54:264-8.
24. Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr. Preoperative evaluation of serum CA 125, TAG72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol 1990;163:1204-9.
25. Nishiya M, Sakuragi N, Hareyama H, Ebina Y, Furuya M, Oikawa M, et al. Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging. Int J Cancer 1998;79:521-5.